NURS FPX 9010 Assessment 3: Project Design and Methodology

Introduction

A well-structured design ensures the rigor, validity, and feasibility of a Doctor of Nursing Practice (DNP) design. This paper presents the design and methodology for a DNP design addressing low drug adherence among hypertensive grown-ups in primary care. The design proposes enforcing a nanny-led digital adherence program that integrates mobile monuments, education, and follow-up to ameliorate adherence and blood pressure control. The design includes population, setting, intervention, data collection, evaluation, and ethical considerations. 

NURS FPX 9010 Assessment 3:Project Purpose and Objectives

The purpose of this DNP design is to ameliorate drug adherence among grown-ups diagnosed with hypertension through a structured nanny-led digital health intervention. 

Objectives:

1. Increase drug adherence by 25 within 12 weeks. 
2. Ameliorate average blood pressure control among actors. 
3. Enhance patient engagement and tone-operation chops. 
4. estimate the feasibility and adequacy of the digital adherence program. 

Project Design

This design will use a quasi-experimental retest-posttest design to estimate changes in adherence and blood pressure before and after perpetration. 

Rationale:
A quasi-experimental design allows practical evaluation in a real-world clinical terrain where randomization isn’t doable. This design supports outgrowth comparison over time and measures the effectiveness of interventions in clinical practice. 

Setting and Population

Setting:
The design will take place in a primary care clinic combined with a large healthcare system serving roughly 3,000 adult cases annually. 

Population:

• Grown-ups aged 30–75 diagnosed with hypertension. 
• specified at least one antihypertensive drug. 
• Own a smartphone and can operate introductory digital operations. 
• Rejection of cognitive impairment or severe comorbidities. 

Sample Size:
A convenience sample of 30 actors will be signed. This size is acceptable for an airman design to assess feasibility and effect size. 

Intervention Description

The nanny-led digital adherence program includes 

• original assessment baseline adherence, blood pressure, and demographic data. 
• Education Session A 20-nanosecond personalized session on hypertension operation and drug significance. 
• Mobile Reminders Daily drug monuments using a secure app. 
• Follow-Up Calls Daily 10-nanosecond nanny calls for provocation, troubleshooting, and underpinning. 
• Post-Intervention Evaluation Adherence and blood pressure reassessment at 12 weeks. 

The intervention aligns with substantiation from previous studies (Chen et al., 2022; Johnson et al., 2022) showing advanced adherence and case satisfaction through nanny-led and digital approaches. 

Data Collection Methods

Quantitative Data:

• Drug Adherence Measured using the Morisky Medication Adherence Scale (MMAS-8). 
• Blood Pressure Measured using a calibrated automatic sphygmomanometer at birth and week 12. 
• Engagement data collected from app operation logs. 

Qualitative Data (Optional):
Short post-intervention interviews will explore party satisfaction and barriers to adherence. 

Data Analysis Plan

• Quantitative paired t-tests will compare pre- and post-intervention adherence and blood pressure. Descriptive statistics (mean, SD, and probabilities) will epitomize demographics and adherence rates. 
• Qualitative Thematic analysis will be used to identify patterns from interview responses. 
• Software IBM SPSS Statistics (Version 29) will be used for quantitative analysis. 

Ethical Considerations

• Institutional Review Board (IRB) blessing will be attained previous to perpetration. 
• Informed concurrence will be secured from all actors. 
• Data will be de-identified to ensure sequestration and confidentiality. 
• Actors can withdraw at any time without penalty. 
• The study poses minimum threat, primarily related to data sequestration. 

Evaluation Plan

Primary Outcome:

• Increase in MMAS-8 adherence scores. 

Secondary Outcomes:

• Reduction in mean systolic/diastolic blood pressure. 
• party satisfaction (check-grounded). 

Evaluation will concentrate on effectiveness, feasibility, and sustainability within the primary care environment. 

Expected Outcomes

• Advanced drug adherence rates (> 25). 
• drop in average systolic BP by 10 mmHg. 
• Positive party feedback regarding the usability and helpfulness of the digital tool. 
• Increased nanny engagement in case-centered technology interventions. 

Conclusion

The proposed nanny-led digital adherence program provides a structured, substantiation-grounded frame for addressing drug nonadherence in hypertensive cases. By integrating technology, education, and follow-up, this DNP design promotes team operation and sustainable health enhancement. The methodology ensures rigor, ethical integrity, and practical connection—laying a strong foundation for perpetration and evaluation in unborn assessments.